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Abstract 
Identification of patients colonised with methicillin resistant Staphylococcus aureus 
(MRSA) and subsequent isolation and decolonisation is pivotal to the control of cross 
infection in hospitals. The aim of this study was to establish if early identification of 
patients using rapid methods alone reduces transmission. A prospective, cluster, two period 
cross-over design was used. Seven surgical wards at a large hospital were allocated to two 
groups, and for the first eight months four wards used rapid MRSA screening and three 
wards used a standard culture method. The groups were reversed for the second eight 
months. Regardless of the method of detection all patients were screened for nasal carriage 
on admission and then every four days. MRSA control measures remained constant. 
Results were analysed using a log linear Poisson regression model. A total of 
12,682/13,952 patient ward episodes (PWE) were included in the study. Admission 
screening identified 453 (3.6%) MRSA positive patient ward episodes, with a further 268 
(2.2%) acquiring MRSA. After adjusting for other variables, rapid screening was shown to 
statistically reduce MRSA acquisition with patients being 1.49 times (p=0.007) more likely 
to acquire MRSA in wards where they were screened using the culture method. Screening 
of surgical patients using rapid testing resulted in a statistically significant reduction in 
MRSA acquisition. This result was achieved in a routine surgical service with high bed 
occupancy and low availability of isolation rooms, making it applicable to the majority of 
health-care systems worldwide. 
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Introduction 
Methicillin resistant Staphylococcus aureus (MRSA) is an important hospital acquired 
infection, the prevalence of which has increased, despite the introduction of multifaceted 
control measures (1;2). Successful control measures have mainly relied upon the 
identification and isolation of colonised and infected patients to prevent them acting as a 
reservoir of infection and onward transmission (3-6). The important unanswered question, 
addressed by this study, is whether a more rapid diagnosis of colonisation or infection 
confers additional benefits over traditional culture-based methods (7). 
 
Recently developed molecular methods, using polymerase chain reaction (PCR) have the 
potential to confirm or refute colonisation and infection of individual patients within two 
hours. One such commercially available real-time PCR test links mecA, the gene 
responsible for methicillin resistance, to a S. aureus genomic background, thereby avoiding 
false positives (8). Several studies have evaluated this test and shown it to have both high 
sensitivity and negative predictive value (9-12). 
 
We have designed and executed a prospective controlled cross-over study within the 
surgical wards of a single large hospital to test the hypothesis that early identification of 
MRSA colonised and infected patients reduces onward transmission of MRSA compared 
to traditional culture based methods.  
 
Materials and Methods 
Study setting and design 
The study was based in a large teaching hospital of 1,200 beds and carried out in seven 
surgical wards (number of wards); general surgery (2), thoracic (1), ear, nose and throat 
(ENT) (1), trauma and orthopaedic (2) and urology (1). Each ward had between 20 and 34 
beds, arranged in bays of six beds and two to five single isolation rooms. 
 
A prospective, cluster two-period cross-over design was used, with the only difference 
between the two periods being the method of MRSA detection (13). The study compared 
the use of rapid MRSA testing with the BD GeneOhm
TM
 molecular test (BD Diagnostics - 
GeneOhm, CA, USA) with a standard direct inoculation culture method using 
chromogenic (MRSA ID) media (Biomerieux, Marcy, l’Etoile, France). Wards were 
assigned to one of two groups (A to D and E to G), with wards of a similar speciality being 
placed in opposite groups. An initial two month pilot period, following group assignment 
and introduction of test methods, was conducted according to the study protocol. This was 
followed by two eight-month cross-over periods, with one month follow up of study 
patients at the end of the final period.  
 
A screening protocol was implemented, requiring all adult patients admitted for >24h to 
have a nasal sample taken on admission. In order to identify transmission events and 
acquisition whilst on the ward, all patients who were negative on admission were re-
screened every four days until discharge. Patients known to be positive from previous 
admission were still screened on admission.  
 
Laboratory procedures and reporting 
On receipt in the laboratory all swabs, including those from the wards where the samples 
were being tested using the rapid test, were inoculated directly onto chromogenic culture 
media. Subsequently the swabs requiring the rapid test were processed according to the 
manufacturer’s instructions. Rapid results were reported immediately on completion of the 
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test and did not await a culture result. Culture plates were read after 18h incubation and 
MRSA isolates confirmed the following day using standard methods (14). Mupirocin 
sensitivity was carried out on all isolates according to British Society Antimicrobial 
Chemotherapy methods. Where there were discrepant results between rapid and culture 
tests, samples were placed in broth enrichment, incubated overnight and then sub-cultured 
onto chromogenic media. Results from all tests were entered on the hospital reporting 
system and all positive MRSA results, rapid and culture, were telephoned. A seven day per 
week service was provided.  
 
Infection control procedures 
All wards were provided with the same infection control guidelines which remained 
unchanged for the duration of the study. Only upon a positive test result were patients 
placed under control measures. These included placing the patients in an isolation room if 
available and placement of an isolation precaution sign detailing the infection control 
measures, including hand hygiene and the wearing of an apron, that should be taken either 
on the entry to the room or above the bed space. Gloves were only required when handling 
blood, body fluids, secretions, excretions and contaminated materials. All patients were 
commenced on decolonisation treatment (nasal mupirocin or naseptin for strains with high 
level mupirocin resistance and triclosan body wash (Aquasept®) administered three times 
a day for five days).  
 
Data collection  
Dedicated staff collected a comprehensive set of data for all patients admitted to the study 
wards. This included demographic information, risk factors, source of admission, antibiotic 
usage, length of stay, bed movements and type of surgery. For all patients who were 
colonised or infected with MRSA, the times of implementation of infection control 
measures and decolonisation treatment were also recorded. Turnaround times for MRSA 
screening results, from taking a sample to reporting, were recorded for all samples. 
 
Outcome measures 
The primary outcome of the study was the acquisition rate of MRSA colonisation. Due to 
differences in sensitivity between the rapid and culture tests, acquisition rates were 
calculated using only culture results which were obtained consistently in all arms of the 
study.  A patient was deemed to be colonised with MRSA on admission to a ward if 
MRSA was isolated within 48h of admission.  If a patient did not have an admission 
sample, but a negative sample was taken within four days of the ward admission, the 
patient was regarded as not being colonised with MRSA on admission.  Patients were 
excluded from the analysis if they had no samples taken or if they had a positive four day 
sample, but no admission sample (Figure 1). 
 
In order to account for colonisation pressure, acquisition rates were calculated as the ratio 
of the number of patients acquiring MRSA on the ward to the number of patients who were 
MRSA positive on admission.  Analysis was carried out at ward level and, to take account 
of the fact that during the study some patients moved between study wards, analysis was 
carried out using patient ward episodes (PWE), i.e. each separate ward admission for the 
same patient was counted. A patient was regarded as being colonised with MRSA from the 
point at which it was first detected and then for the duration of their admission.   
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Statistical Analysis 
A log-linear Poisson regression model was used to analyse counts of new MRSA 
acquisitions on each ward during each study period. The analysis was carried out in SPSS 
v.15. The log of the number of MRSA colonisations on admission to each ward in each 
period was included in the model as an offset variable so that model parameters correspond 
to estimates of the MRSA acquisition rate. A stepwise model fitting approach was adopted 
to investigate the effects of the potential confounding factors, including age, length of stay 
in the ward, proportion of patients undergoing elective or emergency surgery, source of 
admission, critical care admission and antibiotic usage, enabling adjustment of the effect of 
test method (rapid vs. culture) on the number of new MRSA colonisations. Overall model 
improvement was assessed after adding each of the potential confounders and the final 
model retained those variables that were significant at the 5% level.  For comparison, 
MRSA incidence rates per 100 bed days were calculated for each study period.  The rates 
were compared using a log-linear Poisson regression model, adjusted for ward, period and 
test method.  
 
Results 
During the study period (Jan ’05 to Apr ’07) a total of 10,934 patients were admitted to the 
study wards amounting to 13,952 patient ward episodes (PWE). A total of 1,270 (9.1%) 
PWE were excluded from the analysis; 32 (0.2%) had no admission sample taken and 
1,238 (8.8%) had no samples taken. These patients had a shorter length of stay (mean 3 
days) than patients included in the study. Characteristics of the patient groups across the 
study periods are shown in Table 1.  Overall, there were 453 (3.6%) PWE in which the 
patient was MRSA culture positive on admission to the ward; 187 (2.8%) in the culture 
arm and 266 (4.4%) in the rapid arm. Based on culture results only MRSA was acquired 
during 157 (2.4%) PWE in the culture arm and 111 (1.9%) PWE in the rapid arm.  
 
A total of 808 PWE were positive with the rapid test, of which 377 were positive using 
direct culture and a further 140 using broth enrichment. 
 
The final fitted model for MRSA acquisition rate included terms for ward, period (pre or 
post cross-over), log of the mean length of stay on a ward, log of proportion of patients 
undergoing emergency surgery and test method (rapid vs. culture). Logs were taken of the 
two continuous variables (mean length of stay on ward and proportion of patients 
undertaking emergency surgery) to reflect the log link in the Poisson model. There was a 
significant ward effect in the model and a significant period effect after adjusting for all 
other factors (Table 2).  Both length of stay on the ward and the proportion of emergency 
surgical procedures carried out on a ward significantly increased the likelihood of MRSA 
acquisition.  After adjusting for all other variables in the model, the test method (rapid vs. 
culture) was shown to have a significant effect on the numbers of patients acquiring MRSA 
during a ward stay, with an estimated rate ratio of 1.49 (95% confidence interval 1.115-
2.003; p=0.007). This shows that patients on wards during the culture period were 1.49 
times more likely to acquire MRSA than during the rapid period.  The incidence rates per 
100 bed days for the rapid and culture periods were respectively 0.286 and 0.410 
(p=0.002). 
 
Six of the seven wards saw a decrease in the number of MRSA acquisitions during the 
periods of the study when the rapid test was utilised (Table 3). Ward B, an ENT ward 
which has rapid turnover of patients and a low rate of acquisition, saw an increase in the 
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acquisition rate (Table 4 and S3). There was a minor change to the admission policy on 
ward B during the study which resulted in an increase of short stay patients (Table S1).  
 
Turnaround times and compliance with isolation procedures 
The time from sample taking to result reporting was calculated for all samples. The mean 
time for reporting positive results for the rapid test was 0.9 days versus 3.3 days for the 
culture test (Table 4). The mean time from result reporting to decolonisation treatment was 
comparable between the two study periods (Table 4). The percentage of MRSA colonised 
patients nursed in isolation rooms was low in both study arms (Table 4).  
 
Discussion 
The present study has shown, within the rigorous constraints of a controlled trial, that rapid 
MRSA screening significantly reduces MRSA transmission within surgical wards of a 
large hospital when compared with standard culture based techniques. This finding has 
important implications for the control and management of MRSA in institutions where 
MRSA is endemic and there is limited availability of isolation rooms. The shortened 
turnaround time to MRSA result ensures that the risk of transmission occurring from a 
patient not known to be colonised is reduced (6).  
 
In most UK hospitals there are small numbers of single rooms available for patient 
isolation. This explains the very low compliance with isolation in both arms of the study 
(approx 17%) meaning that the dominant intervention was early patient identification; 
resulting in the implementation of infection control precautions and decolonisation 
treatment. Early notification of MRSA in the rapid arm resulted in a greater percentage of 
patients receiving decolonisation treatment, with a higher percentage of the culture arm 
being discharged before the result was available and therefore receiving no decolonisation 
treatment.  
 
Since the introduction of rapid molecular tests other studies have been published 
investigating the impact of these tests on MRSA transmission and infection rates (15-22). 
The majority of these have a retrospective, time intervention study design which does not 
control for confounding variables. Our study adopted a prospective cross-over design, 
enabling the elimination of sampling biases and ensuring, as far as possible, that there were 
no changes to the ward environment or practices during the study. Although the wards 
were not randomised, they were matched as far as possible to ensure that seasonal bias was 
not introduced.  No wash out period was used as no operational changes were required, but 
this did result in an altered length of reporting for 68 (0.5%) patients. 
 
Two other studies have used a cross-over design; the first assessed the impact on infection 
rates of screening patients rapidly on admission versus no screening (20). The second 
assessed the impact of rapid screening versus conventional culture and had a high 
compliance with admission screening (93.4%), but a larger number of patients were lost to 
follow up (17.8%) so that transmission rates may have been underestimated (21). In 
addition,  pre-emptive isolation of patients (i.e before microbiological screening) at high 
risk of MRSA colonisation was used (21). We believe these two factors resulted in a much 
lower detected transmission rate, 0.36 as opposed to 0.84 in our study. 
 
Elucidation of the impact of rapid screening in previous studies has been hampered by the 
introduction of multiple interventions, for example the introduction of rapid screening and 
pre-emptive isolation (19).  
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Re-screening patients every four days may well have contributed to the effectiveness of 
rapid testing, with new acquisitions being identified more promptly. All of the other 
published studies reporting the effects of rapid testing have focused on admission 
screening and used the availability of clinical or discharge samples as evidence of 
transmission. There is evidence that using either clinical samples or discharge screening to 
determine transmission events will result in an under reporting (23-25). Harbarth and 
colleagues used only passive surveillance and, as they acknowledge, this may have resulted 
in some MRSA infections being missed, which they felt the cross-over design would 
account for (20).  However, only patients in the test group were screened for MRSA 
possibly resulting in an increased awareness and reporting of infection in this group.  
 
As has been reported in other studies, some samples were positive using the rapid test and 
we were unable to grow MRSA using direct culture (16). This is partly due to the increased 
sensitivity of molecular tests, with direct inoculation being known to be less sensitive than 
broth enrichment. Interestingly, unlike Conterno and colleagues who deemed all samples 
that were positive using the rapid test and negative using culture to be false positives and 
ceased to isolate and decolonise the patient, the present study continued to treat the patient 
as positive (16), which may account for the differing results from the two studies. 
 
Our study provided a challenging test of the value of rapid versus slower culture based 
methods for MRSA screening because of the limited availability of isolation rooms (26). 
We conclude that the introduction of MRSA screening using rapid tests and the protocol 
we have described can significantly reduce MRSA transmission on wards that have a 
limited number of isolation rooms. 
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Figure 1: Flow of patients through the study 
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Table 1: Patient characteristics from the two study periods, all of the above data, 
apart from total number of patients relates to patient ward episodes. 
 
 
STUDY PERIOD 
 
 
p-value 
CULTURE RAPID 
Total number of patient ward episodes (PWEs) 7493 6459 <0.001 
Number of PWEs excluded from analysis 822 (11.0%) 448 (6.9%) <0.001 
Number of admission samples 6671 6011 <0.001 
Number of post admission samples 8516 9292 <0.001 
Age (mean, years) 57.1 59.1 0.157 
Male 3663 (54.9%] 3425 (57.0%] 0.005 
Patients admitted from nursing home 68 (1.0%] 76 (1.3%] 0.505 
Patients admitted from other hospital ward 1053 (15.8%] 1016 (16.9%] 0.416 
Mean length of stay on ward (days) 6.5 7.2 0.374 
Mean length of hospital stay (days) 9.7 10.6 0.365 
Patient undergoing surgical procedure 2807 (42.1%] 2989 (49.7%] 0.017 
Emergency surgery 1429 (21.4%] 1411 (23.5%] 0.736 
Antibiotic prophylaxis 1700 (25.5%] 1779 (29.6%] 0.180 
Antibiotics (excluding prophylaxis) 1258 (18.9%] 1223 (20.3%] 0.482 
Ward episode followed by admission to critical care 551 (8.3%] 558 (9.3%] 0.455 
Ward episode following discharge from critical care 665 (10.0%] 638 (10.6%] 0.834 
 
Log-linear Poisson models, adjusted for ward, were used to compare counts in the two 
arms.  Two-sample t-tests were used to compare the within-ward differences in 
lengths of stay and mean ages, allowing for ward and period effects. These were 
carried out in SPSS V.15. A random effects logistic regression model was used to 
compare the proportion of PWE excluded from the two arms using SAS v.9.1. 
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Table 2: Parameter estimates and rate ratios for the fitted log-linear model.  
 
Parameter 
Estimated rate 
ratio 
95% C.I. p-value 
Period (Pre or post cross over] 0.356 (0.230, 0.701) < 0.001 
log(mean length of stay on ward] 89.971 (13.782, 587.362) < 0.001 
log(emergency surgery]* 27.694 (4.260, 180.058)  0.001 
Test method: culture 
(rapid test is reference level] 
1.494 (1.115, 2.003) 0.007 
 
*log(emergency surgery] = log(proportion of patients undertaking emergency surgery 
on each ward] 
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Table 3: MRSA transmission rates for each study period (culture vs. rapid) based on culture positive sample (* Wards which were in the 
molecular arm of the study first) 
 
Ward Speciality 
 
CULTURE 
 
RAPID 
Number of 
patient ward 
episodes 
 
MRSA 
positive on 
admission 
to ward 
 
 
MRSA 
acquired 
during ward 
admission 
 
 
MRSA 
acquisition 
ratio 
Number of 
patient ward 
episodes 
 
MRSA 
positive on 
admission 
to ward 
 
 
MRSA 
acquired 
during ward 
admission 
 
 
MRSA 
acquisition 
ratio 
A * Thoracic 997 18 36 2.0 1088 58 18 0.31 
B * Ear, nose, throat 1933 27 4 0.15 894 22 6 0.27 
C * General surgery  1050 32 20 0.63 1070 60 34 0.57 
D * 
Trauma and 
orthopaedics 
543 16 11 0.69 479 17 8 0.47 
E Urology 638 29 36 1.24 788 43 15 0.35 
F General surgery 1065 41 38 0.93 1171 49 23 0.47 
G 
Trauma and 
orthopaedics 
445 24 12 0.50 521 17 7 0.41 
Total All 6671 187 157 0.84 6011 266 111 0.42 
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Table 4: Compliance with infection control guidelines. The rapid arm calculations are made 
using data only from those patients who were positive by both the rapid test and culture. 
 
 
STUDY PERIOD  
p-value 
CULTURE RAPID 
MRSA colonisation on admission 187 266 <0.001 
MRSA acquisition 157 111 0.005 
Total colonised with MRSA 344 377 0.219 
Mean length of time on the ward to MRSA 
acquisition (days] 
13.0  12.9  
0.894 
Percentage isolated in isolation rooms 16.3% (56/344) 17.5% (66/377) <0.001 
Percentage prescribed decolonisation treatment 41.3% (142/344) 71.1% (268/377) <0.001 
Mean length of time to MRSA positive result 
reporting (days]* 
3.3  0.9  
<0.001 
Mean length of time from reporting to prescribing 
decolonisation treatment (days] 
0.7  0.7  
1.000 
 
* Denominator figures represent ward episodes in which MRSA colonisation was first detected 
** Log-linear Poisson models, adjusted for ward, were used to compare counts in the two arms.  Two-
sample t-tests were used to compare the within-ward differences in lengths of time, allowing for ward 
and period effects. 
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SUPPLEMENTARY TABLES 
 
Table S1: Number of patients/corresponding patient ward episodes (PWEs) and number of samples tested on each ward for each of the study 
periods. 
 
 
 
 
Ward 
CULTURE RAPID 
Patients Patient 
ward 
episodes 
Excluded 
PWE’s 
PWE’s 
included 
in 
analysis 
Admission 
samples 
Post-
admission 
samples 
Total 
samples 
Patients Patient 
ward 
episodes 
Excluded 
PWE’s 
PWE’s 
included 
in 
analysis 
Admission 
samples 
Post-
admission 
samples 
Total 
samples 
A 
904 1048 
51 
(4.9%) 
997 
(95.1%) 
997 1611 2608 
1014 1132 
44 
(3.9%) 
1088 
(96.1%) 
1088 1755 2843 
B 
1981 2121 
188 
(8.9%) 
1933 
(91.1%) 
1933 1283 3216 
958 1016 
122 
(12.0%) 
894 
(88.0%) 
894 735 1629 
C 
1116 1248 
198 
(15.9%) 
1050 
(84.1%) 
1050 1025 2075 
1048 1159 
89 
(8.5%) 
1070 
(92.3%) 
1070 1569 2639 
D 
603 616 
73 
(11.9%) 
543 
(88.1%) 
543 967 1510 
509 526 
47 
(8.9%) 
479 
(91.1%) 
479 1116 1595 
E 
600 709 
71 
(10.0%) 
638 
(90.0%) 
638 1004 1642 
673 808 
20 
(2.5%) 
788 
(97.5%) 
788 1298 2086 
F 
1163 1260 
195 
(15.5%) 
1065 
(84.5%) 
1065 1372 2437 
1147 1267 
96 
(7.6%) 
1171 
(92.4%) 
1171 1689 2860 
G 
481 491 
46 
(9.4%) 
445 
(90.6%) 
445 1254 1699 
535 551 
30 
(5.4%) 
521 
(94.6%) 
521 1130 1651 
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Table S2: Patient demographics, source of admission to ward and length of stay (ward and hospital] on each ward between the two study periods. 
 
 
 
 
 
Ward 
 
CULTURE 
 
RAPID 
 
Age 
(mean, 
years] 
 
Gender 
Source of admission to ward 
Length of 
stay 
(mean, days] 
 
Age 
(mean, 
years] 
 
Gender 
Source of admission to ward 
Length of 
stay 
(mean, days] 
Male Female 
Own 
home 
Nurse 
home 
Hosp 
ward 
Ward Hosp Male Female 
Own 
home 
Nurse 
home 
Hosp 
ward 
Ward Hosp 
A 57.2 
626 
(62.8%] 
371 
(37.2%] 
771 
(77.3%] 
1 
(0.1%] 
225 
(22.6%] 
7.4 9.1 56.9 
702 
(64.5%] 
386 
(35.5%] 
853 
(78.4%] 
3  
(0.3%] 
232 
(21.3%] 
7.1 9.3 
B 52.2 
974 
(50.4%] 
959 
(49.6%] 
1808 
(93.5%] 
5 
(0.3%] 
120 
(6.2%] 
2.0 3.0 53.9 
420 
(47.0%] 
474 
(53.0%] 
835 
(93.4%] 
1  
(0.1%] 
58 (6.5%] 3.7 5.7 
C 59.4 
543 
(51.7%] 
507 
(48.3%] 
766 
(73.0%] 
14 
(1.3%] 
270 
(25.7%] 
6.8 10.5 60.9 
566 
(52.9%] 
504 
(47.1%] 
895 
(83.6%] 
14 
(1.3%] 
161 
(15.0%] 
7.6 11.4 
D 58.8 
273 
(50.3%] 
270 
(49.7%] 
429 
(79.0%] 
11 
(2.0%] 
103 
(19.0%] 
10.5 17.6 60.1 
256 
(53.4%] 
223 
(46.6%] 
367 
(76.6%] 
15 
(3.1%] 
97 
(20.3%] 
13.0 22.4 
E 64.2 
442 
(69.3%] 
196 
(30.7%] 
529 
(82.9%] 
11 
(1.7%] 
98 
(15.4%] 
8.0 11.7 64.4 
546 
(69.3%] 
242 
(30.7%] 
638 
(81.0%] 
10 
(1.3%] 
140 
(17.8%] 
5.8 7.8 
F 56.7 
613 
(57.6%] 
452 
(42.4%] 
911 
(85.5%] 
11 
(1.0%] 
143 
(13.4%] 
7.2 11.2 58.7 
717 
(61.2%] 
454 
(38.8%] 
907 
(77.5%] 
13 
(1.1%] 
251 
(21.4%] 
6.5 9.6 
G 62.1 
192 
(43.1%] 
253 
(56.9%] 
336 
(75.5%] 
15 
(3.4%] 
94 
(21.1%] 
14.3 21.8 61.2 
218 
(41.8%] 
303 
(58.2%] 
424 
(82.3%] 
20 
(3.8%] 
77 
(14.8%] 
10.8 16.2 
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Table S3: Adherence to infection control procedures upon detection of an MRSA positive patient for each ward for each of the two study periods. 
 
 
 
 
 
 
 
Ward 
 
CULTURE 
 
 
RAPID 
Mean 
length of 
time on 
ward to 
MRSA 
acquisition 
(days] 
Mean 
length of 
time to 
MRSA 
positive 
result 
reporting 
(days] 
Mean length of 
time from 
reporting to 
decolonisation 
treatment 
(days] 
Number 
of 
patients 
isolated 
in side 
rooms 
Number of 
patients 
prescribed 
decolonisation 
treatment 
Mean 
length of 
time on 
ward to 
MRSA 
acquisition 
(days] 
Mean 
length of 
time to 
MRSA 
positive 
result 
reporting 
(days] 
Mean length of 
time from 
reporting to 
decolonisation 
treatment 
(days] 
Number 
of 
patients 
isolated 
in side 
rooms 
Number of 
patients 
prescribed 
decolonisation 
treatment 
A 12.8 3.3  0.6 17 
(32.1%] 
22       
(41.5%] 
10.7 0.8 0.6 35 
(22.3%] 
117     
(74.5%] 
B 8.3 3.3  0.2 0 
(0.0%] 
6         
(19.4%] 
14.2 0.6 0.6 14 
(19.2%] 
44       
(60.3%] 
C 13.8 2.9  0.6 14 
(28.6%] 
22       
(44.9%] 
15.4 0.8 0.7 18 
(12.0%] 
111     
(74.0%] 
D 9.7 3.0  0.1 1 
(4.8%] 
7         
(33.3%] 
19.3 0.7 1.2 6 
(8.6%] 
58       
(82.9%] 
E 13.4 3.4 0.9 6 
(10.2%] 
32       
(54.2%] 
8.1 1.0 0.3 11 
(10.7%] 
82       
(79.6%] 
F 13.8 3.6 0.7 8 
(10.7%] 
35       
(46.7%] 
13.4 0.7 0.6 23 
(16.1%] 
112     
(78.3%] 
G 13.4 3.3 1.0 4 
(13.3%] 
19 
(63.3%] 
6.4 0.7 0.5 9 
(15.3%] 
52 
(88.1%] 
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